Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
11/28/2006 | CA2026915C Stem cell factor |
11/28/2006 | CA1341516C Preparation of factor x111a by gene manipulation |
11/23/2006 | WO2006125068A2 Production of enzymes |
11/23/2006 | WO2006124269A2 Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders |
11/23/2006 | WO2006123926A2 Peptide composition for growing and/or culturing micro-organisms and/or cells |
11/23/2006 | WO2006123829A1 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
11/23/2006 | WO2006123445A1 Method of displaying protein |
11/23/2006 | WO2006093998A3 Process and genes for expression and over-expression of active [fefe] hydrogenases |
11/23/2006 | WO2006055778A3 Immunoglobulin variable region cassette exchange |
11/23/2006 | WO2005116267A3 Emission ratiometric indicators of phosphorylation by c-kinase |
11/23/2006 | WO2005038002A3 Site-specific incorporation of redox active amino acids into proteins |
11/23/2006 | WO2004022720A3 Methods for identifying antimicrobial compounds |
11/23/2006 | US20060265787 Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
11/23/2006 | US20060265769 Gab2 (p97) gene and methods of use thereof |
11/23/2006 | US20060265767 Compositions and methods for treatment of autoimmune and related diseases |
11/23/2006 | US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay |
11/23/2006 | US20060264615 Which induce proliferation of lymphocytes in presence of wild-type p35 polypeptide subunit of human interleukin-12; site directed mutagenesis |
11/23/2006 | US20060264613 Soluble CTLA4 proteins produced by recombinant DNA methods; autoimmune diseases, transplant rejection; inhibits the co-stimulatory pathway in T cell activation |
11/23/2006 | US20060264612 Optimised protein synthesis |
11/23/2006 | US20060264611 Pancreatic islet transcription factor and uses thereof |
11/23/2006 | US20060264610 Protein complexes of the tip60 transcriptional activator protein |
11/23/2006 | US20060264609 Use of heat shock proteins |
11/23/2006 | US20060264606 Processes for making acylated insulin |
11/23/2006 | US20060264603 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide |
11/23/2006 | US20060264392 Modulators of angiogenesis |
11/23/2006 | US20060264373 Modified vitamin K-dependent polypeptides |
11/23/2006 | US20060264370 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith |
11/23/2006 | US20060263882 Multi-cistronic vectors for gene transfer protocols |
11/23/2006 | US20060263877 Novel megakaryocytic protein tyrosine kinase 1 |
11/23/2006 | US20060263867 Delta-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts |
11/23/2006 | US20060263866 Delta-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts |
11/23/2006 | US20060263861 Method for producing beta-hydroxy amino acid and enzyme used therefor |
11/23/2006 | US20060263858 Hyaluronan synthase genes and expression thereof in Bacillus hosts |
11/23/2006 | US20060263857 Compositions and methods for immunomodulation in an organism |
11/23/2006 | US20060263856 Expression technology for proteins containing a hybrid isotype antibody moiety |
11/23/2006 | US20060263855 Intein-mediated protein purification using in vivo expression of an elastin-like protein |
11/23/2006 | US20060263854 Immunodiagnostic assays using reducing agents |
11/23/2006 | US20060263853 Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders |
11/23/2006 | US20060263852 Asp2 |
11/23/2006 | US20060263851 Soluble interleukin-20 receptor |
11/23/2006 | US20060263850 to inhibit cytokine-mediated inflammation; two polypeptide subunits, IL-20RA (formerly ZcytoR7) and IL-20RB (formerly DIRS1); one subunit fused to constant region of light chain of an immunoglobulin; the other fused to constant region of heavy chain; light and heavy chains connected via a disulfide bond |
11/23/2006 | US20060263849 The analogs are resistant to diaminopeptidase IV degradation and bind zinc; are active over an extended time in vivo |
11/23/2006 | US20060263848 Cysteine-containing peptides having antioxidant properties |
11/23/2006 | US20060263847 Compositions and methods for treatment of sever acute respiratory syndrome (sars) |
11/23/2006 | US20060263846 S. penumoniae antigens |
11/23/2006 | US20060263838 Soluble pyrroloquinoline quinone; culturing microorganisms; thermal stability |
11/23/2006 | US20060263828 Arrestin chimera comprising naturally occurring beta-arrestin-2 and naturally occurring ubiquitin moiety, where arrestin chimera has increased affinity for GPCR, and where increased affinity means that arrestin chimera remains associated with and traffics with GPCR into endosomes |
11/23/2006 | US20060263820 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins |
11/23/2006 | US20060263804 Functional influenza virus-like particles (VLPs) |
11/23/2006 | US20060263788 Human kinase interacting protein 2 (KIP2)-related gene variant (KIP2V1) associated with prostate cancer |
11/23/2006 | US20060263787 Immunoglobulin-like variable chain binding polypeptides and methods of use |
11/23/2006 | US20060263786 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer |
11/23/2006 | US20060263776 Serine protease |
11/23/2006 | US20060263775 cDNA molecule of a mammalian ELF3 gene; associated with cancer, including ELF3 mRNA intron retention, a novel ELF3 5' untranslated region, and a novel Alu, Alukwd |
11/23/2006 | US20060263774 Nucleotide sequences, vectors, transformed host cells, polypeptides, antibodies; monocyte/macrophage mediated disorders |
11/23/2006 | US20060263770 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
11/23/2006 | US20060263377 Surface protein of Leptospira |
11/23/2006 | US20060263366 Neoplasm specific antibodies and uses thereof |
11/23/2006 | US20060263361 Pan-kir2dl nk -receptor antibodies and their use in diagnostik and therapy |
11/23/2006 | US20060263356 antibody binding to IL-13R alpha 1, inhibiting IL-13 bioactivity; comprising variable heavy and light chain amino acid sequences CDR1, CDR2, and CDR3; useful in the treatment of asthma and allergic diseases |
11/23/2006 | US20060263353 untagged antigen is used in conjunction with a polyclonal antibody to isolate cells recognizing the antigen; for cancers, autoimmune or inflammatory disorders |
11/23/2006 | US20060263345 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
11/23/2006 | US20060263334 Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen |
11/23/2006 | DE102006019794A1 Use of glycerylglycosides for stimulating aquaporin expression and in the preparation of cosmetics |
11/23/2006 | CA2607291A1 Compositions and methods for modulating immune responses |
11/23/2006 | CA2606576A1 High-level expression of recombinant antibody in a mammalian host cell |
11/23/2006 | CA2597511A1 Hivcon: an hiv immunogen and uses thereof |
11/22/2006 | EP1724354A2 Circular DNA molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
11/22/2006 | EP1724349A1 TIE Ligand Homologues |
11/22/2006 | EP1724342A1 Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli |
11/22/2006 | EP1724284A2 GLP-1 fusion proteins |
11/22/2006 | EP1722808A2 Egf receptor epitode peptides and uses thereof |
11/22/2006 | EP1722760A2 Delivery of genes encoding short hairpin rna using receptor-specific nanocontainers |
11/22/2006 | EP1626981A4 Dipeptidyl-peptidase protected proteins |
11/22/2006 | EP1558746A4 Nucleic acids encoding duramycin |
11/22/2006 | EP1556694A4 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
11/22/2006 | EP1373571B1 Functional surface display of polypeptides |
11/22/2006 | EP1370575B1 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
11/22/2006 | EP1266025B1 Protein scaffolds for antibody mimics and other binding proteins |
11/22/2006 | EP1163522B1 Method for detecting msrv-1 induced superantigen activity in a biological sample |
11/22/2006 | EP1078054B1 Monomeric mp52/gdf-5 with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone |
11/22/2006 | EP1037603B1 Membrane virus host range mutations and their uses as vaccine substrates |
11/22/2006 | EP1015570B1 Fibrin microbeads and uses thereof |
11/22/2006 | EP0999273B1 HUMAN GENE RecQ4 ENCODING HELICASE |
11/22/2006 | EP0939821B1 G-beta-gamma regulated phosphatidylinositol-3' kinase |
11/22/2006 | EP0935415B1 In vitro methods for delivering nucleic acids into a cell |
11/22/2006 | EP0890105B1 Methods related to Alzheimer's disease for diagnosis, manufacture of medicaments and screening of substances and beta-amyloid related peptides |
11/22/2006 | EP0825996B1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
11/22/2006 | EP0783003B1 G-CSF TPO fusion proteins |
11/22/2006 | EP0574461B2 High affinity humanized monoclonal antibodies |
11/22/2006 | CN1867669A Method for producing gamma-carboxylated proteins |
11/22/2006 | CN1867581A Il-21衍生物 Il-21 derivatives |
11/22/2006 | CN1865445A scFvC6.5-sTrail fusion gene and protein, and its preparation |
11/22/2006 | CN1285732C Method for preparing polyclonal antibody of human vascular endothelial growth factor |
11/22/2006 | CN1285731C Method for enzyme hydrolyzing zein through two steps method |
11/22/2006 | CN1285608C Parainfluenza virus glycoproteins and vaccines |
11/22/2006 | CN1285381C Chemokine mutants in treatment of multiple sclerosis |
11/21/2006 | US7139665 Generating mutant aminoacyl transfer RNA synthetase for de novo design of artificial proteins |
11/21/2006 | US7138568 Expression vector coding insecticidal protein for use in the transformation and generation of moth resistant leafy plants |
11/21/2006 | US7138515 Translational activity-promoting higher-order structure |